Markets: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), 世界のその他の地域, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
Batch Size: Small, Medium, Large
Category / Product: FDF / DRUG PRODUCTS
Compliance: EMA (EU GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), FDA (cGMP), ECOVADIS, ISO, Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
Controlled Substances: Lowest potential for abuse
BSL (Biological Safety Level): 3, 1, 2
Use: Human, Veterinary
Services: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Region: North America

Adare Pharma Solutions
Adare Pharma es un CDMO global con instalaciones en EE.UU. UE では、製品の開発と製造の中間体験を行っています。
Markets: DIGEMID (Peru), ANMAT (Argentina), EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
Batch Size: Small, Medium, Large
Category / Product: FDF / DRUG PRODUCTS, SERVICES, PARTICLE ENGINEERING
Compliance: EMA (EU GMP), PMDA/MHLW (Japan GMP), UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NMPA (China GMP), ECOVADIS, ISO, Halal Research Council, Health Canada (Canada GMP), TITCK (Turkish Health Authorities), MFDS/KFDA (Republic of Korea GMP)
Use: Human, Veterinary
Services: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Region: North America
Therapeutic Areas of Expertise (ATC): (C) Cardiovascular system, (A) Digestive tract and metabolism
Batch Size: Small, Medium, Large
Use: Human
Services: Logistics, Manufacturing services, Packaging
Region: North America
Markets: FDA (USA), Health Canada (Canada)
Compliance: FDA (cGMP), NSF, Halal Research Council, Health Canada (Canada GMP)
Category / Product: NUTRACEUTICALS
MAI network supplier
組換えタンパク質とモノクローナル抗体 (mAb) に重点を置く開発製造受託機関 (CDMO)。
登録後に利用できる場所
MAI network supplier
高度な無菌および非無菌医薬品の製造、製剤開発、分析試験を行う信頼できる GMP CDMO。
登録後に利用できる場所
MAI network supplier
商用 API 低分子合成。
登録後に利用できる場所
これらの機能は主な基準に一致しますが、オプションのフィルターのすべてに一致するとは限りません。
MAI network supplier
製薬CRO/CMO
登録後に利用できる場所
MAI network supplier
非常に複雑な低分子 API のための高度な CDMO プラットフォーム、プエルトリコのグアヤマ。概要 Skalar Pharma は最も確立された API メーカーの 1 つを運営しています
登録後に利用できる場所
MAI network supplier
優れた品質と規制 • FDA cGMP に準拠 (21 CFR Part 210 & 211) • ICH Q7 準拠の運用 • 包括的な品質管理システム • CAPA および C
登録後に利用できる場所
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.